Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 18536708)

1.

A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder.

Evans KC, Simon NM, Dougherty DD, Hoge EA, Worthington JJ, Chow C, Kaufman RE, Gold AL, Fischman AJ, Pollack MH, Rauch SL.

Neuropsychopharmacology. 2009 Jan;34(2):390-8. doi: 10.1038/npp.2008.69. Epub 2008 Jun 4.

2.

Low-dose tiagabine effectiveness in anxiety disorders.

Schaller JL, Thomas J, Rawlings D.

MedGenMed. 2004 Sep 17;6(3):8.

3.

Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers.

Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA.

J Cereb Blood Flow Metab. 1996 May;16(3):418-26.

4.

Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers.

Kimbrell TA, Dunn RT, George MS, Danielson AL, Willis MW, Repella JD, Benson BE, Herscovitch P, Post RM, Wassermann EM.

Psychiatry Res. 2002 Oct 1;115(3):101-13.

PMID:
12208488
5.

The neural correlates of social anxiety disorder and response to pharmacotherapy.

Kilts CD, Kelsey JE, Knight B, Ely TD, Bowman FD, Gross RE, Selvig A, Gordon A, Newport DJ, Nemeroff CB.

Neuropsychopharmacology. 2006 Oct;31(10):2243-53. Epub 2006 Mar 8. Erratum in: Neuropsychopharmacology. 2006 Oct;31(10):2254.

6.

Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder.

Dodhia S, Hosanagar A, Fitzgerald DA, Labuschagne I, Wood AG, Nathan PJ, Phan KL.

Neuropsychopharmacology. 2014 Aug;39(9):2061-9. doi: 10.1038/npp.2014.53. Epub 2014 Mar 5.

PMID:
24594871
7.

The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.

Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K.

J Clin Psychiatry. 2005 Nov;66(11):1401-8.

PMID:
16420077
8.

Open-label tiagabine monotherapy for major depressive disorder with anxiety.

Carpenter LL, Schecter JM, Tyrka AR, Mello AF, Mello MF, Haggarty R, Price LH.

J Clin Psychiatry. 2006 Jan;67(1):66-71.

PMID:
16426090
9.

Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.

Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ.

Arch Gen Psychiatry. 2003 Jan;60(1):14-22.

PMID:
12511168
10.

Regional cerebral brain metabolism correlates of neuroticism and extraversion.

Deckersbach T, Miller KK, Klibanski A, Fischman A, Dougherty DD, Blais MA, Herzog DB, Rauch SL.

Depress Anxiety. 2006;23(3):133-8.

PMID:
16470804
11.

Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load.

Derache N, Marié RM, Constans JM, Defer GL.

J Neurol Sci. 2006 Jun 15;245(1-2):103-9. Epub 2006 Apr 27.

PMID:
16647086
13.

Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.

Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM.

Biol Psychiatry. 2002 Feb 1;51(3):237-52.

PMID:
11839367
14.

Regional brain responses to serotonin in major depressive disorder.

Anderson AD, Oquendo MA, Parsey RV, Milak MS, Campbell C, Mann JJ.

J Affect Disord. 2004 Nov 1;82(3):411-7.

PMID:
15555692
15.

Resting state amygdala-prefrontal connectivity predicts symptom change after cognitive behavioral therapy in generalized social anxiety disorder.

Klumpp H, Keutmann MK, Fitzgerald DA, Shankman SA, Phan KL.

Biol Mood Anxiety Disord. 2014 Dec 9;4(1):14. doi: 10.1186/s13587-014-0014-5. eCollection 2014.

16.

Tiagabine does not attenuate alcohol-induced activation of the human reward system.

Fehr C, Hohmann N, Gründer G, Dielentheis TF, Buchholz HG, Chechko N, Yakushev I, Landvogt C, Bartenstein P, Urban R, Schreckenberger M.

Psychopharmacology (Berl). 2007 May;191(4):975-83. Epub 2007 Jan 30.

PMID:
17265078
17.

Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Milak MS, Parsey RV, Lee L, Oquendo MA, Olvet DM, Eipper F, Malone K, Mann JJ.

Psychiatry Res. 2009 Jul 15;173(1):63-70. doi: 10.1016/j.pscychresns.2008.09.004. Epub 2009 May 14.

18.

Regional brain glucose uptake distinguishes suicide attempters from non-attempters in major depression.

Sublette ME, Milak MS, Galfalvy HC, Oquendo MA, Malone KM, Mann JJ.

Arch Suicide Res. 2013;17(4):434-47. doi: 10.1080/13811118.2013.801813.

19.

Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder.

Brooks JO 3rd, Wang PW, Bonner JC, Rosen AC, Hoblyn JC, Hill SJ, Ketter TA.

J Psychiatr Res. 2009 Jan;43(3):181-8. doi: 10.1016/j.jpsychires.2008.04.015. Epub 2008 Jun 25.

20.

Towards a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep.

Nofzinger EA, Price JC, Meltzer CC, Buysse DJ, Villemagne VL, Miewald JM, Sembrat RC, Steppe DA, Kupfer DJ.

Psychiatry Res. 2000 Apr 10;98(2):71-91.

PMID:
10762734
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk